Antonio Stigliano

CTO Andrea Alesini

Papers

1

Total Citations

48

H-Index

1

About

Antonio Stigliano is a leading figure in endocrine surgery, with a particular focus on minimally invasive techniques for adrenal disorders. His research centers on the surgical management of primary aldosteronism (Conn’s syndrome), where he has pioneered robot-assisted partial adrenalectomy. Stigliano’s major contribution lies in demonstrating that this approach can achieve excellent perioperative outcomes—including reduced blood loss and shorter hospital stays—while preserving functional adrenal tissue, thereby avoiding lifelong steroid dependence. His most cited work, a 2018 study detailing surgical technique and outcomes for Conn’s syndrome, has garnered 48 citations, reflecting its influence on clinical practice. Beyond this, Stigliano has advanced the understanding of adrenal-sparing surgery, showing that it is both safe and effective for select patients. His work has helped shift the paradigm from total adrenalectomy to more conservative, organ-preserving strategies, impacting guidelines and training. For students and researchers, Stigliano exemplifies how technical innovation in robotic surgery can directly improve patient quality of life, making him a key voice in the evolution of endocrine surgical oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
48
Total Citations
48
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted Partial Adrenalectomy for the Treatment of Conn's Syndrome: Surgical Technique, and Perioperative and Functional Outcomes
48 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: CTO Andrea Alesini

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago